dilated cardiomyopathy heart failure caused mutation phospholamban 
molecular etiologies heart failure emerging cardiovascular epidemic affecting million americans costing billion health-care dollars annually remain poorly understood report inherited human dilated cardiomyopathy refractory congestive heart failure caused dominant arg -> cys missense mutation residue r9c phospholamban pln transmembrane phosphoprotein inhibits cardiac sarcoplasmic reticular ca2+-adenosine triphosphatase serca2a pump transgenic plnr9c mice recapitulated human heart failure premature death cellular biochemical studies revealed unlike wild-type pln plnr9c directly inhibit serca2a rather plnr9c trapped protein kinase pka blocked pka-mediated phosphorylation wild-type pln turn delayed decay calcium transients myocytes results indicate myocellular calcium dysregulation can initiate human heart failure-a finding may lead therapeutic opportunities 
